Similarly, IL-8 interferes with the chemotherapeutic responses through analogous processes, promoting cancer cell survival and growth, recruiting immune cells that may protect tumor cells from the effects of chemotherapy, upregulating drug efflux pumps, and altering the tumor microenvironment [25,28]. The gene discussed is CXCL8; the disease is neoplasm.